This post was originally published on this site
Glucagon-like peptide-1 receptor agonists, or GLP-1s, are commonly prescribed to treat type-2 diabetes, but have more recently been approved for weight loss. If US adults are being prescribed GLP-1 drugs for weight loss through their health plan, they’re likely getting coverage through insurance that’s employer-sponsored, recent studies suggest.
More employers covering GLP-1s. Most health plans offered through the Affordable Care Act (ACA) marketplace cover GLP-1s for diabetes, but not for weight loss, a recent Kaiser Family Foundation (KFF) analysis found. While 82% of ACA plans include Ozempic for diabetes in their formularies, for example, just 1% cover either Saxenda or Wegovy,